1. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of Moyamoya disease in the United States. Stroke. 1998; Jul. 29(7):1347–51.
2. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995; Mar. 194(3):671–80.
3. Grandhi R, Zwagerman NT, Lee P, Jovin T, Okonkwo DO. Iatrogenic pseudoaneurysm of the middle meningeal artery after external ventricular drain placement. J Neuroimaging. 2015; Jan-Feb. 25(1):140–1.
4. Kim H, Jang DK, Han YM, Sung JH, Park IS, Lee KS, et al. Direct bypass versus indirect bypass in adult Moyamoya angiopathy with symptoms or hemodynamic instability: a meta-analysis of comparative studies. World Neurosurg. 2016; Oct. 94:273–84.
5. Komiyama M, Yasui T, Tamura K, Nagata Y, Fu Y, Yagura H. Chronic subdural hematoma associated with middle meningeal arteriovenous fistula treated by a combination of embolization and burr hole drainage. Surg Neurol. 1994; Oct. 42(4):316–9.
6. Luciani A, Houdart E, Mounayer C, Saint Maurice JP, Merland JJ. Spontaneous closure of dural arteriovenous fistulas: report of three cases and review of the literature. AJNR Am J Neuroradiol. 2001; May. 22(5):992–6.
7. Madhusudan HV, Krishnamoorthy N, Suresh PK, Subramaniam V. Superficial temporal artery pseudoaneurysm presenting as extradural hematoma: a case report and review of literature. Asian J Neurosurg. 2015; Apr-Jun. 10(2):63–5.
8. Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with Moyamoya disease in the US. Neurosurg Focus. 2008; 24(2):E15.
9. Nabors MW, Azzam CJ, Albanna FJ, Gulya AJ, Davis DO, Kobrine AI. Delayed postoperative dural arteriovenous malformations. Report of two cases. J Neurosurg. 1987; May. 66(5):768–72.
10. Pourdanesh F, Salehian M, Dehghan P, Dehghani N, Dehghani S. Pseudoaneurysm of the superficial temporal artery following penetrating trauma. J Craniofac Surg. 2013; Jul. 24(4):e334–7.
11. Qian C, Yu X, Li J, Chen J, Wang L, Chen G. The efficacy of surgical treatment for the secondary prevention of stroke in symptomatic Moyamoya disease: a meta-analysis. Medicine (Baltimore). 2015; Dec. 94(49):e2218.
12. Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J. Risk factors for neurologic deterioration after revascularization surgery in patients with Moyamoya disease. Anesth Analg. 1997; Nov. 85(5):1060–5.
13. Skaf GS, Domloj NT, Salameh JA, Atiyeh B. Pseudoaneurysm of the superficial temporal artery: a complication of botulinum toxin injection. Aesthetic Plast Surg. 2012; Aug. 36(4):982–5.
14. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, et al. Perioperative complications and long-term outcomes after bypasses in adults with Moyamoya disease: a systematic review and meta-analysis. World Neurosurg. 2016; Aug. 92:179–88.
15. Vadivelu S, Xin X, Loven T, Restrepo G, Chalif DJ, Setton A. Iatrogenic dural arteriovenous fistula and aneurysmal subarachnoid hemorrhage. Neurosurg Focus. 2012; May. 32(5):E1.
16. Yilmaz EY, Pritz MB, Bruno A, Lopez-Yunez A, Biller J. Moyamoya: Indiana University Medical Center experience. Arch Neurol. 2001; Aug. 58(8):1274–8.